1Ovbiagele B, Kidwell CS, Saver JL. Expanding indications for statins in cerebral ischemia: a quantitative study [ J ]. Arch Neurol,2005,62:67 -72. 被引量：1
2Savi P, Combalbert J, Gaich C, et al. The antiaggregating activity of clopidogrel is due to ametabolic activation by the hepatic cytochrome P45021A [J]. Thromb Haemost,1994,72:313-317. 被引量：1
3Savi P, Pereillo JM, Uzabiaga MF, et al. Identification and biological activity of the active metabolite of clopidogrel [J]. Thromb Haemost, 2000,84:891-896. 被引量：1
4Clarke TA, Waskell LA. The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin [ J ]. Drug Metab Dispos ,2003,31:53-59. 被引量：1
5Miserez AR, Rossi FA, Keller U. Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects [ J ]. Eur J Clin Pharmacol, 1994,46 ( 2 ) : 107-114. 被引量：1
6Narita Y,Kitazoe Y, Okuhara Y, et al. Increase or decrease of HDL- cholesterol concentrations during pravastatin treatment depending on the per-treatment HDL-cholesterol levels [ J ]. Eur J Clin Pharmacol, 1997,52(6) :461-463. 被引量：1
7James AL, Michael AB, Stephen DW, et al. Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes:Phase Z of the A to Z Trial [ J]. JAMA,2004,292: 1307-1316. 被引量：1
